Harold E Bays Selected Research

Glucose (Dextrose)

1/2022	Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.
3/2017	Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels.
4/2014	Canagliflozin: effects in overweight and obese subjects without diabetes mellitus.
1/2014	Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus.
7/2013	Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.
1/2012	Long-term (52-78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients.
11/2011	Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
10/2008	Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
4/2008	Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia.
7/2007	Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harold E Bays Research Topics

Disease

27	Dyslipidemias (Dyslipidemia) 03/2022 - 03/2002
26	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 03/2008
22	Hypercholesterolemia 12/2021 - 11/2002
17	Hypertriglyceridemia 03/2024 - 11/2002
16	Coronary Disease (Coronary Heart Disease) 01/2017 - 07/2004
13	Obesity 03/2024 - 08/2004
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2007
9	Diabetes Mellitus 03/2017 - 09/2007
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 02/2005
8	Overweight 03/2024 - 09/2009
7	Atherosclerosis 08/2017 - 03/2007
7	Flushing 09/2012 - 03/2003
4	Hypertension (High Blood Pressure) 03/2024 - 04/2008
4	Weight Loss (Weight Reduction) 12/2023 - 11/2009
4	Gout 10/2023 - 01/2019
4	Inflammation (Inflammations) 01/2016 - 03/2008
3	Myocardial Infarction 04/2023 - 12/2016
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2016
3	Body Weight (Weight, Body) 01/2020 - 09/2009
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2016 - 07/2007
3	Muscular Diseases (Myopathy) 11/2014 - 04/2006
3	Hypertrophy 07/2013 - 03/2008
3	Pancreatitis 09/2012 - 03/2008
3	Hyperlipidemias (Hyperlipidemia) 06/2012 - 11/2002
3	Metabolic Diseases (Metabolic Disease) 03/2011 - 01/2009
2	Cholelithiasis 10/2023 - 04/2023
2	Stroke (Strokes) 04/2023 - 01/2021
2	Infections 03/2017 - 04/2014
2	Hypoglycemia (Reactive Hypoglycemia) 03/2017 - 01/2014
2	Insulin Resistance 07/2013 - 03/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2012 - 03/2003
2	Nasopharyngitis 12/2008 - 07/2007

Drug/Important Bio-Agent (IBA)

45	LipidsIBA 01/2022 - 03/2002
27	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023 - 11/2002
25	Triglycerides (Triacylglycerol)IBA 08/2019 - 07/2003
23	LDL CholesterolIBA 12/2021 - 11/2002
19	oxidized low density lipoproteinIBA 12/2021 - 12/2002
16	HDL CholesterolIBA 08/2017 - 03/2003
14	CholesterolIBA 01/2016 - 11/2002
13	Ezetimibe (Zetia)FDA Link 12/2021 - 11/2002
12	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2015 - 03/2002
12	Atorvastatin (Lipitor)FDA Link 10/2014 - 03/2003
10	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 10/2023 - 09/2013
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2007
10	Simvastatin (Zocor)FDA LinkGeneric 07/2017 - 11/2002
10	Lipoproteins (Lipoprotein)IBA 05/2016 - 01/2003
8	eicosapentaenoic acid ethyl esterIBA 01/2022 - 02/2013
8	Rosuvastatin Calcium (Crestor)FDA Link 10/2014 - 12/2002
7	EstersIBA 01/2022 - 07/2007
7	MK-0524IBA 01/2015 - 03/2008
7	Colesevelam Hydrochloride (Welchol)FDA Link 07/2014 - 04/2006
6	LDL Lipoproteins (beta Lipoproteins)IBA 08/2011 - 11/2002
5	C-Reactive ProteinIBA 01/2023 - 04/2006
5	Eicosapentaenoic AcidIBA 01/2022 - 02/2013
5	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 03/2008
5	ApolipoproteinsIBA 08/2017 - 04/2008
5	Pravastatin (Pravachol)FDA LinkGeneric 09/2007 - 12/2002
4	alirocumabIBA 08/2017 - 10/2014
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2012 - 03/2007
4	Fenofibrate (CiL)FDA LinkGeneric 04/2011 - 04/2006
4	Lovastatin (Mevacor)FDA LinkGeneric 09/2007 - 03/2002
3	Phentermine (Adipex-P)FDA LinkGeneric 03/2024 - 01/2017
3	Blood Glucose (Blood Sugar)IBA 03/2022 - 09/2007
3	lipoprotein cholesterolIBA 11/2019 - 03/2016
3	Apolipoproteins B (ApoB)IBA 08/2017 - 04/2011
3	Biomarkers (Surrogate Marker)IBA 07/2017 - 11/2014
3	Bile Acids and Salts (Bile Acids)IBA 01/2016 - 10/2008
3	Metformin (Glucophage)FDA LinkGeneric 01/2012 - 10/2008
3	fenofibric acid FDA Link 09/2010 - 12/2008
2	fibroblast growth factor 21IBA 03/2024 - 01/2023
2	Antihypertensive Agents (Antihypertensives)IBA 03/2024 - 04/2008
2	Topiramate (Topamax)FDA LinkGeneric 03/2024 - 06/2022
2	tirzepatideIBA 12/2023 - 06/2022
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 06/2022 - 08/2004
2	CanagliflozinIBA 01/2017 - 04/2014
2	remnant-like particle cholesterolIBA 10/2016 - 04/2008
2	Apolipoprotein C-IIIIBA 05/2016 - 11/2011
2	Trace Elements (Biometals)IBA 01/2016 - 01/2016
2	CarbohydratesIBA 01/2016 - 01/2016
2	FatsIBA 01/2016 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 09/2013
2	Hormones (Hormone)IBA 01/2016 - 01/2016
2	Immunologic Factors (Immunomodulators)IBA 01/2016 - 01/2016
2	MineralsIBA 01/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2016
2	VitaminsIBA 01/2016 - 01/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 11/2014 - 04/2006
2	Insulin (Novolin)FDA Link 07/2013 - 01/2012
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 02/2013 - 11/2011
2	Hemoglobin AIBA 01/2012 - 10/2008
2	lorcaserinIBA 03/2011 - 11/2009
2	prostaglandin D2 receptorIBA 12/2009 - 11/2008
2	HDL LipoproteinsIBA 02/2009 - 03/2003
2	ProstaglandinsIBA 01/2009 - 03/2008
2	TabletsIBA 11/2008 - 11/2004

Therapy/Procedure

33	Therapeutics 12/2021 - 11/2002
6	Drug Therapy (Chemotherapy) 06/2022 - 09/2014
4	Bariatric Surgery 06/2022 - 07/2013
3	Glycemic Control 03/2017 - 07/2013
2	Blood Component Removal (Apheresis) 01/2016 - 11/2014